Cargando…

Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate

Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimic...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarneri, Claudio, Tchernev, Georgi, Wollina, Uwe, Lotti, Torello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ID Design 2012/DOOEL Skopje 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535664/
https://www.ncbi.nlm.nih.gov/pubmed/28785339
http://dx.doi.org/10.3889/oamjms.2017.136
_version_ 1783253883207811072
author Guarneri, Claudio
Tchernev, Georgi
Wollina, Uwe
Lotti, Torello
author_facet Guarneri, Claudio
Tchernev, Georgi
Wollina, Uwe
Lotti, Torello
author_sort Guarneri, Claudio
collection PubMed
description Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimicrobials are commonly used, very rarely in dermatology. The authors describe the first case occurred after intralesional administration of meglumine antimoniate and briefly discuss the pathogenetic hypotheses on this atypical adverse drug reaction.
format Online
Article
Text
id pubmed-5535664
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher ID Design 2012/DOOEL Skopje
record_format MEDLINE/PubMed
spelling pubmed-55356642017-08-07 Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate Guarneri, Claudio Tchernev, Georgi Wollina, Uwe Lotti, Torello Open Access Maced J Med Sci Case Report Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 1959, few cases have been reported in medical literature and, although antimicrobials are commonly used, very rarely in dermatology. The authors describe the first case occurred after intralesional administration of meglumine antimoniate and briefly discuss the pathogenetic hypotheses on this atypical adverse drug reaction. ID Design 2012/DOOEL Skopje 2017-07-21 /pmc/articles/PMC5535664/ /pubmed/28785339 http://dx.doi.org/10.3889/oamjms.2017.136 Text en Copyright: © 2017 Claudio Guarneri, Georgi Tchernev, Uwe Wollina, Torello Lotti. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
spellingShingle Case Report
Guarneri, Claudio
Tchernev, Georgi
Wollina, Uwe
Lotti, Torello
Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title_full Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title_fullStr Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title_full_unstemmed Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title_short Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
title_sort hoigne syndrome caused by intralesional meglumine antimoniate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535664/
https://www.ncbi.nlm.nih.gov/pubmed/28785339
http://dx.doi.org/10.3889/oamjms.2017.136
work_keys_str_mv AT guarnericlaudio hoignesyndromecausedbyintralesionalmeglumineantimoniate
AT tchernevgeorgi hoignesyndromecausedbyintralesionalmeglumineantimoniate
AT wollinauwe hoignesyndromecausedbyintralesionalmeglumineantimoniate
AT lottitorello hoignesyndromecausedbyintralesionalmeglumineantimoniate